References
- Belgisch kankerrregister. Available from: www.kankerregister.org
- Kitahara CM, Sosa JA. The changing incidence of thyroid cancer. Nat Rev Endocrinol. 2016;12(11):646–653.10.1038/nrendo.2016.110
- Ahn HS, Kim HJ, Welch HG. Korea’s thyroid-cancer ‘epidemic’ – screening and overdiagnosis. N Engl J Med. 2014;371(19):1765–1767.10.1056/NEJMp1409841
- Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA. 2006;295(18):2164–2167.10.1001/jama.295.18.2164
- Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg. 2014;140(4):317–322.10.1001/jamaoto.2014.1
- Ito Y, Nikiforov YE, Schlumberger M, et al. Increasing incidence of thyroid cancer: controversies explored. Nat Rev Endocrinol. 2013;9(3):178–184.10.1038/nrendo.2012.257
- Leenhardt L, Bernier MO, Boin-Pineau MH, et al. Advances in diagnostic practices affect thyroid cancer incidence in France. Eur J Endocrinol. 2004;150(2):133–139.10.1530/eje.0.1500133
- Van den Bruel A, Francart J, Dubois C, et al. Regional variation in thyroid cancer incidence in Belgium is associated with variation in thyroid imaging and thyroid disease management. J Clin Endocrinol Metab. 2013;98(10):4063–4071.10.1210/jc.2013-1705
- Francart J, Van Den Bruel A, Decallonne B, et al. Regional differences in thyroid cancer incidence in Belgium: role of diagnostic and therapeutic strategies for thyroid disease – Appendix. Health Services Research (HSR). Brussels: Belgian Health Care Knowledge Centre (KCE). 2012. KCE Report 177C. D/2012/10.273/25. https://kce.fgov.be
- Davies L. How understanding thyroid cancer in belgium can help us mitigate the problem of increasing incidence. J Clin Endocrinol Metab. 2013;98(10):3977–3979.10.1210/jc.2013-3505
- Cooper DS, Doherty GM, Haugen BR, et al. American Thyroid Association guidelines taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2006;16(2):109–142.10.1089/thy.2006.16.109
- Pacini F, Schlumberger M, Dralle H, et al. European Thyroid Cancer Taskforce. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol. 2006;154(6):787–803.10.1530/eje.1.02158
- Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. American Thyroid Association (ATA) Guidelines Taskforce on thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167–1214.10.1089/thy.2009.0110
- Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133.10.1089/thy.2015.0020
- Cibas ES, Ali SZ. The Bethesda system for reporting thyroid cytopathology. Thyroid. 2009;19(11):1159–1165.10.1089/thy.2009.0274
- Edge SB, Byrd DR, Compton CC, et al. Thyroid cancer staging. In: Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC cancer staging manual. 7th ed. New York, NY: SpringerVerlag; 2010. p. 59–64.
- Ahn HS, Kim HJ, Kim KH, et al. Thyroid cancer screening in South Korea increases detection of papillary cancers with no impact on other subtypes or thyroid cancer mortality. Thyroid. 2016;26(11):1535–1540.10.1089/thy.2016.0075
- Ritter K, Elfenbein D, Schneider DF, et al. Hypoparathyroidism after total thyroidectomy: incidence and resolution. J Surg Res. 2015;197(2):348–353.10.1016/j.jss.2015.04.059
- Rosato L, Avenia N, Bernante P, et al. Complications of thyroid surgery: analysis of a multicentric study on 14,934 patients operated on in italy over 5 years. World J Surg. 2004;28(3):271–276.10.1007/s00268-003-6903-1